SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sirna Therapeutics Inc
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
562 31 0 RNAI
Emcee:  advinfo Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
387DNA Technology Patent GrantedRPI Broadens Patent Portfolio With DNAzyme Rights bob zagorin-12/19/2000
386Hi Bob, Thanks for the 8-k link. Nothing new here. Any view as to motivation fThomas-12/6/2000
385RIBOZYME PHARMACEUTICALS INC has filed a Form 8-K (Current Report) with the Unitbob zagorin-12/5/2000
384RPI Announces Shareholder Rights Plan BOULDER, Colo., Nov. 22 /PRNewswire/ -- Rbob zagorin-11/22/2000
383RIBOZYME PHARMACEUTICALS INC has filed a Form 10-Q (Quarterly Report) with the Ubob zagorin-11/14/2000
382Ribozyme Pharmaceuticals, Inc. Reports Third Quarter Financial Results BOULDER,bob zagorin-11/13/2000
381RPI Files Shelf Registration and Restates 2nd Quarter Earnings BOULDER, Colo., bob zagorin-11/6/2000
380Hepatitis C and B Ribozyme Results Presented at AASLD Noted Hepatologists Will bob zagorin-10/31/2000
379Hepatitis C Virus Patent Issued to RPI;Product Portfolio Strengthened BOULDER, bob zagorin-10/18/2000
378for the file Ribozyme presented cell-culture data from several ribozymes designebob zagorin-10/4/2000
377bob, FWIW: tfc.com Cheers, Tucktuck-10/4/2000
376starting from a fairly large position (for me) in RZYM that i built up in the mibob zagorin-10/2/2000
375Stock is breaking down and breaking support. Billbillkirn-10/2/2000
374Reading the Yahoo board, a consensus seems to be developing that Heptazyme may nbillkirn-10/1/2000
373Thomas: Thank you for doing some additional research. I am afraid this event mbillkirn-9/29/2000
372Hi Bill & Bob (& glad to see that Bob is on his toes again ;), I listeneThomas-9/29/2000
371Bob: Serious move! I think it was Lilly that returned Viracept to Agouron. Agoubillkirn-9/28/2000
370RPI to Initiate Phase II Clinical Trials on Anti-Hepatitis C Drug BOULDER, Colobob zagorin-9/28/2000
369just got home from a poker game and catching up on emails.bob zagorin-9/27/2000
368Hi Bob, A little slow on the draw on that one ;-) The stock took a beating todaThomas-9/27/2000
367Hepatitis B Product Development Program Announced and Ribozyme Data Presented Bbob zagorin-9/27/2000
366Bob, I would agree. News will drive the young bio's. Interesting week for RHG-9/1/2000
365maybe. i believe in TA and use it every day but with biotechs, news drives the sbob zagorin-8/26/2000
364Short term double top or break out? We are at the point of determination. Not billkirn-8/26/2000
363What do y'all make of this? Message 14214665 Cheers, Tucktuck-8/15/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News